Jim Simons
WGS icon

Jim Simons’s GeneDx Holdings WGS Stock Holding History

Jim Simons’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.87M Buy
153,716
+96,400
+168% +$8.79M 0.02% 978
2025
Q4 		$7.45M Buy
+57,316
New +$7.87M 0.01% 1069
2025
Q2 		– Sell
-70,216
Closed -$6.22M – 3948
2025
Q1 		$6.22M Sell
70,216
-134,900
-66% -$11.7M 0.01% 1292
2024
Q4 		$15.8M Buy
205,116
+111,543
+119% +$7.79M 0.02% 770
2024
Q3 		$3.97M Buy
93,573
+3,200
+4% +$108K 0.01% 1592
2024
Q2 		$2.36M Buy
+90,373
New +$1.71M ﹤0.01% 1775
2023
Q2 		– Sell
-13,745
Closed -$166K – 4305
2023
Q1 		$166K Sell
13,745
-61,503
-82% -$820K ﹤0.01% 3342
2022
Q4 		$655K Buy
75,248
+67,360
+854% +$1.48M ﹤0.01% 2782
2022
Q3 		$228K Sell
7,888
-21,828
-73% -$999K ﹤0.01% 3334
2022
Q2 		$1.24M Buy
29,716
+17,683
+147% +$1.2M ﹤0.01% 2566
2022
Q1 		$1.22M Sell
12,033
-18,036
-60% -$2M ﹤0.01% 2599
2021
Q4 		$4.43M Buy
+30,069
New +$6.72M 0.01% 1615

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jim Simons's WGS Position: Q1 2026 in Review

Jim Simons increased its GeneDx Holdings (WGS) stake by 168% in Q1 2026, buying an estimated $8.79M and bringing the position to 153,716 shares worth $9.87M. The position accounts for 0.02% of the portfolio, ranked #978.

Jim Simons first reported a position in WGS in Q4 2021 and has held it in 12 quarters since. The position peaked at $15.8M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Jim Simons held 153,716 shares of GeneDx Holdings worth $9.87M as of Q1 2026.
  • Jim Simons bought 96,400 GeneDx Holdings shares in Q1 2026, an estimated $8.79M.
  • GeneDx Holdings made up 0.02% of Jim Simons's portfolio in Q1 2026, its #978 holding.
  • Jim Simons first reported a position in GeneDx Holdings in Q4 2021 and has held it in 12 quarters since.
  • Jim Simons's GeneDx Holdings position peaked at $15.8M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.